Jefferies Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Jefferies Group’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-27,325	Closed	-$2.65M	–	3254
2019 Q3	$2.65M	Buy	27,325 +22,104	+423%	+$2.21M	0.02%	905
2019 Q2	$535K	Buy	+5,221	New	+$563K	﹤0.01%	1635
2017 Q4	–	Sell	-26,100	Closed	-$2.33M	–	2952
2017 Q3	$2.33M	Buy	26,100 +18,067	+225%	+$1.37M	0.02%	871
2017 Q2	$480K	Buy	+8,033	New	+$449K	﹤0.01%	1628
2016 Q4	–	Sell	-2,200	Closed	-$132K	–	2615
2016 Q3	$132K	Sell	2,200 -1,900	-46%	-$110K	﹤0.01%	2005
2016 Q2	$210K	Buy	+4,100	New	+$175K	﹤0.01%	1803

Jefferies Group's ONCE Position: Q4 2019 in Review

Jefferies Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 27,325 shares — an estimated $2.65M sold.

Jefferies Group first reported a position in ONCE in Q2 2016 and held it in 6 quarters. The position peaked at $2.65M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Jefferies Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Jefferies Group sold 27,325 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.65M.
Jefferies Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2016 and held it in 6 quarters.
Jefferies Group's Spark Therapeutics, Inc. Common Stock position peaked at $2.65M in Q3 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.